SUVRETTA CAPITAL MANAGEMENT, LLC - 26 Mar 2025 Form 4 Insider Report for Benitec Biopharma Inc. (BNTC)

Role
Director, 10%+ Owner
Signature
Suvretta Capital Management, LLC; By: /s/Andrew Nathanson , General Counsel & Chief Compliance Officer
Issuer symbol
BNTC
Transactions as of
26 Mar 2025
Net transactions value
+$11,700,000
Form type
4
Filing time
28 Mar 2025, 16:51:41 UTC
Previous filing
26 Dec 2024
Next filing
02 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BNTC Common stock, par value $0.0001 per share Purchase $10,319,400 +793,800 +9.9% $13.00 8,793,245 26 Mar 2025 See footnotes F1, F2
transaction BNTC Common stock, par value $0.0001 per share Purchase $1,380,600 +106,200 +11% $13.00 1,066,764 26 Mar 2025 See footnotes F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Notes are included on Exhibit 99.1.
F2 Notes are included on Exhibit 99.1.
F3 Notes are included on Exhibit 99.1.

Remarks:

Exhibit List: Exhibit 99.1 - Explanation of Responses Exhibit 99.2 - Joint Filer Information Exhibit 99.3 - Joint Filers' Signature